Scotiabank raised the firm’s price target on WM (WM) to $265 from $260 and keeps an Outperform rating on the shares. The firm remains positive on the stock, coming away from the company’s investor day more positive on the Healthcare segment, the analyst tells investors. Scotiabank expects WM to continue raising the dividend at a “strong pace” and resume buybacks when the leverage ratio normalizes.

Don’t Miss TipRanks’ Half Year Sale

• Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

• Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas" href="https://thefly.com/?utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">Try Now>>

>;elm:context_link;itc:0;sec:content-canvas" href="https://www.tipranks.com/screener/top-insider-trading-stocks/?type=stockAnalysisLanding&utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">See Insiders’ Hot Stocks on TipRanks >>

Read More on WM:

Disclaimer & DisclosureReport an Issue

• WM price target raised to $250 from $244 at CIBC

• WM price target raised to $245 from $241 at BMO Capital

• WM price target raised to $255 from $251 at Oppenheimer

• Waste Management: Balancing Growth Potential with Near-Term Challenges

• Waste Management: Balancing Promising Growth with Market Uncertainties